DK1105141T3 - Phosphatidylcholin som et medikament med slimhindebeskyttende virkning - Google Patents

Phosphatidylcholin som et medikament med slimhindebeskyttende virkning

Info

Publication number
DK1105141T3
DK1105141T3 DK99952284T DK99952284T DK1105141T3 DK 1105141 T3 DK1105141 T3 DK 1105141T3 DK 99952284 T DK99952284 T DK 99952284T DK 99952284 T DK99952284 T DK 99952284T DK 1105141 T3 DK1105141 T3 DK 1105141T3
Authority
DK
Denmark
Prior art keywords
phosphatidylcholine
protective effect
intestine
drug
colon
Prior art date
Application number
DK99952284T
Other languages
English (en)
Inventor
Wolfgang Stremmel
Original Assignee
Wolfgang Stremmel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19857750A external-priority patent/DE19857750A1/de
Application filed by Wolfgang Stremmel filed Critical Wolfgang Stremmel
Application granted granted Critical
Publication of DK1105141T3 publication Critical patent/DK1105141T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK99952284T 1998-08-06 1999-08-06 Phosphatidylcholin som et medikament med slimhindebeskyttende virkning DK1105141T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19835526 1998-08-06
DE19857750A DE19857750A1 (de) 1998-08-06 1998-12-15 Phosphatidylocholin als Arzneimittel mit schleimhautschützender Wirkung
PCT/DE1999/002426 WO2000007577A2 (de) 1998-08-06 1999-08-06 Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung

Publications (1)

Publication Number Publication Date
DK1105141T3 true DK1105141T3 (da) 2004-03-08

Family

ID=26047966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99952284T DK1105141T3 (da) 1998-08-06 1999-08-06 Phosphatidylcholin som et medikament med slimhindebeskyttende virkning

Country Status (7)

Country Link
US (1) US6677319B1 (da)
EP (1) EP1105141B1 (da)
JP (1) JP2002522381A (da)
AT (1) ATE253369T1 (da)
DK (1) DK1105141T3 (da)
ES (1) ES2211184T3 (da)
WO (1) WO2000007577A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
DE102005045152A1 (de) 2005-09-21 2007-03-22 Stremmel, Wolfgang, Prof. Dr. Verwendung von therapeutisch wirksamen Lipiden nebst Verfahren zur Herstellung von Organ-/Gewebe-spezifischen therapeutisch wirksamen Lipiden
CN102988373A (zh) 2006-07-19 2013-03-27 德克萨斯大学系统董事会 用于治疗炎性肠病的磷脂与含有5-氨基水杨酸之药物的制备物
PT2185158E (pt) * 2007-07-31 2014-03-27 Pat Gmbh Utilização de fosfatidilcolina para tratar colite ulcerosa dependente de esteróides e refractária a esteróides
CN102958519B (zh) * 2010-06-30 2016-01-13 特罗伊卡药品有限公司 包含扑热息痛的药物组合物及其制备方法
AU2014243102B2 (en) * 2013-03-26 2018-04-26 Lipid Therapeutics Gmbh Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
AU2017284499A1 (en) * 2016-06-17 2019-01-31 Osaka University Intratumoral vein formation promoter

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease
JPS6147418A (ja) 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5498608A (en) 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
DE69525150T2 (de) * 1994-04-01 2002-09-05 Abbott Lab Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
CA2253593C (en) * 1996-05-23 2008-07-08 Novartis Ag Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)

Also Published As

Publication number Publication date
WO2000007577A8 (de) 2000-12-21
WO2000007577A2 (de) 2000-02-17
WO2000007577A3 (de) 2000-10-26
ES2211184T3 (es) 2004-07-01
ATE253369T1 (de) 2003-11-15
EP1105141B1 (de) 2003-11-05
EP1105141A2 (de) 2001-06-13
JP2002522381A (ja) 2002-07-23
US6677319B1 (en) 2004-01-13

Similar Documents

Publication Publication Date Title
PT814784E (pt) Utilizacao de farmacos anti-inflamatorios nao esteroides (nsaids) para o tratamento de carcinomas das celulas escamosas da cavidade oral ou orofaringea
CO4940409A1 (es) Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
BR9814378A (pt) Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
WO2002098352A3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
DE69731610D1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
DK1105141T3 (da) Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
NO994431L (no) Ny formulering
CR7049A (es) Empleo de flumazenilo en la elaboracion de una medicacion para el tratamiento de la dependencia del alcohol
BR0010546A (pt) Terapia antiinflamatória para infecção mediada inflamatória
AR036085A1 (es) Formas de dosificacion y procedimiento para su fabricacion
ES2163000T3 (es) Suministro topico de farmacos al tracto gastrointestinal inferior.
EE04661B1 (et) Viirus-indutseeritud ssteemse šoki ja hingamispuudulikkuse reverseerimine lmfotoksiin-beeta raja blokeerimise abil
IT1318667B1 (it) Medicamento antinfiammatorio.
PT1150704E (pt) Melagatran para o tratamento da inflamacao
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
EP1626731A4 (en) ANTI-INFLAMMATORY MEDICINE PREPARATIONS FOR INFLAMMATORY INFLAMMATION AND THE THERAPY OR PROPHYLAXIS OF GASTRIC TOXICITY
DK1124566T3 (da) Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
BRPI0410998A (pt) derivados de indol com efeito de indução de apoptose